Summit Therapeutics Logo

Summit Therapeutics

🇺🇸
SMMT
US86627T1088

Summit Therapeutics is a US-based biopharmaceutical company specializing in the clinical development of innovative oncology therapies. The company focuses on researching and delivering novel drugs for solid tumors, particularly for patients with non-small cell lung cancer, to improve their treatment options.

Next Quarterly Earnings

Wednesday, November 11, 2026
CW 46
After-Hours
In 76 days

After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).

Quiet period starts on October 14, 2026

Stock Price

Frequently asked questions

When will Summit Therapeutics report its next quarterly earnings?

Summit Therapeutics is scheduled to report its next quarterly earnings on 11/11/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).

When did Summit Therapeutics last report quarterly earnings?

Summit Therapeutics last reported quarterly earnings on 7/23/2026 (Q2 2026). Earnings per share (EPS) came in at -0.28 USD.

How does Summit Therapeutics stock react to earnings?

Across its last 3 earnings reports, Summit Therapeutics stock moved by ±9.9% on average the following day. The largest reaction was -24.9% on 04/30/2026; 1 of 3 reactions were positive.

How often has Summit Therapeutics beaten expectations?

Summit Therapeutics has beaten analyst EPS estimates in 1 of its last 5 evaluated quarters (beat rate: 20%).

How do I add the Summit Therapeutics earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q3 2026
Estimate:-$0.28
Actual:
Q2 2026
Missed
Estimate:-$0.27
Actual:-$0.28
Difference:-$0.01
Q1 2026
Beat
Estimate:-$0.28
Actual:-$0.24
Difference:+$0.04
Price reaction (1 day):-24.9 %
Price reaction (7 days):-20.1 %
Q4 2025
Missed
Estimate:-$0.08
Actual:-$0.29
Difference:-$0.21
Price reaction (1 day):+0.2 %
Price reaction (7 days):+0.6 %
Q3 2025
Missed
Estimate:-$0.04
Actual:-$0.23
Difference:-$0.19
Price reaction (1 day):-4.6 %
Price reaction (7 days):-7.3 %
Q1 2025
Missed
Estimate:-$0.07
Actual:-$0.57
Difference:-$0.50

Earnings statistics

Stock reaction to earnings

±9.9%
Avg. next-day move
-24.9%
Largest move (04/30/2026)
33.3%
Share of positive reactions
±9.3%
Avg. move after 7 days

Basis: price reactions to the last 3 report dates (close to close).

Estimates vs. results

1/5
Quarters above estimates
20%
Beat rate
-54.9%
Avg. EPS surprise

Basis: 5 quarters with an analyst estimate and reported EPS.

Past price reactions are not a reliable indicator of future performance.

Company Information

Name
Summit Therapeutics
Ticker Symbol
SMMT
ISIN
US86627T1088
Country
🇺🇸
USA
Sector